GlassScriptPhysician profile
Nicole Laird
NPI 1528383908
$947.06
in general payments reported to CMS, 2019-2025
17 companies · $151 in 2025
The $151 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $55.73 · 2021: $102 · 2022: $77.62 · 2023: $111 · 2024: $159 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $315.14 | 2019-2024 | Dyanavel Xr |
| Cranial Technologies, INC | $155.98 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $112.92 | 2019-2024 | Jornay Pm |
| Neos Therapeutics, LP | $45.77 | 2019 | |
| Kaleo, INC. | $40.13 | 2021-2022 | |
| Glaxosmithkline, LLC. | $40.11 | 2019-2023 | Bexsero, Pediarix, Rotarix |
| Biomarin Pharmaceutical INC. | $36.00 | 2024 | Voxzogo 1.2mg |
| Acadia Pharmaceuticals INC | $32.48 | 2025 | Daybue |
| Sanofi Pasteur INC. | $31.01 | 2019-2023 | |
| Corium, LLC | $24.28 | 2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $23.10 | 2023 | Qelbree |
| Pfizer INC. | $18.05 | 2025 | |
| Soleno Therapeutics, INC. | $16.94 | 2025 | Vykat Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $14.62 | 2019 | |
| Phadia US INC. | $14.32 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $13.70 | 2025 | Jornay Pm |
| Shire North American Group INC | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Laird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.